<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1478" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1478/" /><meta name="ncbi_pagename" content="Parkin Type of Early-Onset Parkinson Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Parkin Type of Early-Onset Parkinson Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Parkin Type of Early-Onset Parkinson Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/04/04" /><meta name="citation_author" content="Norbert Brüggemann" /><meta name="citation_author" content="Christine Klein" /><meta name="citation_pmid" content="20301651" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1478/" /><meta name="citation_keywords" content="E3 ubiquitin-protein ligase parkin" /><meta name="citation_keywords" content="PRKN" /><meta name="citation_keywords" content="Parkin Type of Early-Onset Parkinson Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Parkin Type of Early-Onset Parkinson Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Norbert Brüggemann" /><meta name="DC.Contributor" content="Christine Klein" /><meta name="DC.Date" content="2013/04/04" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1478/" /><meta name="description" content="Parkin type of early-onset Parkinson disease is characterized by rigidity, bradykinesia, and resting tremor. Lower-limb dystonia may be a presenting sign. Onset usually occurs between ages 20 and 40 years with an average age of onset in the early to mid-thirties. The disease is slowly progressive and disease duration of more than 50 years has been reported. Clinical signs vary; hyperreflexia is common. Dyskinesia as a result of treatment with levodopa frequently occurs." /><meta name="og:title" content="Parkin Type of Early-Onset Parkinson Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Parkin type of early-onset Parkinson disease is characterized by rigidity, bradykinesia, and resting tremor. Lower-limb dystonia may be a presenting sign. Onset usually occurs between ages 20 and 40 years with an average age of onset in the early to mid-thirties. The disease is slowly progressive and disease duration of more than 50 years has been reported. Clinical signs vary; hyperreflexia is common. Dyskinesia as a result of treatment with levodopa frequently occurs." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1478/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/jpd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1478/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8ADAA1DFC87C5100000000063F0339.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1478_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1478_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pkan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/parkinson-overview/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1478_"><span class="title" itemprop="name">Parkin Type of Early-Onset Parkinson Disease</span></h1><p class="contrib-group"><span itemprop="author">Norbert Br&#x000fc;ggemann</span>, MD and <span itemprop="author">Christine Klein</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1478_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1478_ai__"><div class="contrib half_rhythm"><span itemprop="author">Norbert Br&#x000fc;ggemann</span>, MD<div class="affiliation small">Institute of Neurogenetics and Department of Neurology<br />University of Luebeck<br />Luebeck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@nnameggeurb.trebron" class="oemail">ed.kcebeul-inu.oruen@nnameggeurb.trebron</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Christine Klein</span>, MD<div class="affiliation small">Institute of Neurogenetics and Department of Neurology<br />University of Luebeck<br />Luebeck, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.kcebeul-inu.oruen@nielk.enitsirhc" class="oemail">ed.kcebeul-inu.oruen@nielk.enitsirhc</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 17, 2001</span>; Last Update: <span itemprop="dateModified">April 4, 2013</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="jpd.Summary" itemprop="description"><h2 id="_jpd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Parkin type of early-onset Parkinson disease is characterized by rigidity, bradykinesia, and resting tremor. Lower-limb dystonia may be a presenting sign. Onset usually occurs between ages 20 and 40 years with an average age of onset in the early to mid-thirties. The disease is slowly progressive and disease duration of more than 50 years has been reported. Clinical signs vary; hyperreflexia is common. Dyskinesia as a result of treatment with levodopa frequently occurs.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of parkin type of early-onset Parkinson disease is considered primarily in individuals with early-onset parkinsonism (age &#x0003c;40 years), particularly if <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance is suspected. <i>PRKN</i> (formerly <i>PARK2</i>), the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the protein parkin, is the only gene in which pathogenic variants are known to cause parkin type of early-onset Parkinson disease. The diagnosis of parkin type of early-onset Parkinson disease can only be confirmed when pathogenic variants are identified on both alleles of <i>PRKN</i> (i.e., the individual is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the same pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for two different pathogenic alleles). The variant detection frequency varies by family history and age of onset.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Levodopa and other dopaminergic agonists; deep brain stimulation (DBS) for those experiencing difficulty with levodopa therapy.</p><p><i>Prevention of secondary complications:</i> Do not use levodopa therapy above the dose needed for satisfactory clinical response.</p><p><i>Surveillance:</i> Neurologic follow-up including assessment of treatment every six to 12 months.</p><p><i>Agents/circumstances to avoid:</i> Neuroleptic treatment may exacerbate parkinsonism.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Parkin type of early-onset Parkinson disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Each unaffected sib has a 2/3 chance of being a carrier. Carrier testing and prenatal testing for pregnancies at increased risk are possible if both pathogenic alleles have been identified in an affected family member.</p></div></div><div id="jpd.Diagnosis"><h2 id="_jpd_Diagnosis_">Diagnosis</h2><div id="jpd.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Parkin type of early-onset Parkinson disease is often clinically indistinguishable from Parkinson disease of other etiologies [<a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>]. Rigidity, bradykinesia, and resting tremor are variably combined in both disorders.</p><p>The following findings suggest parkin type of early-onset Parkinson disease:</p><ul><li class="half_rhythm"><div>Early onset (age &#x0003c;40 years) or, rarely, juvenile onset (age &#x0003c;20 years). Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals appear to have onset before age 40 years.</div></li><li class="half_rhythm"><div>Lower-limb dystonia, which may be a presenting sign or occurs during disease progression. This finding can sometimes be present in isolation for years.</div></li><li class="half_rhythm"><div>Hyperreflexia of the lower extremities</div></li><li class="half_rhythm"><div>Well-preserved sense of smell</div></li><li class="half_rhythm"><div>Marked and sustained response to oral administration of levodopa, which is frequently associated with levodopa-induced motor fluctuations and dyskinesias (abnormal involuntary movements)</div></li><li class="half_rhythm"><div>Slow disease progression</div></li><li class="half_rhythm"><div>Absence of dementia in most cases (prevalence &#x0003c;3%)</div></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul></div><div id="jpd.Testing"><h3>Testing</h3><p>No clinical investigations distinguish individuals with parkin type of early-onset Parkinson disease from those with Parkinson disease of other etiologies.</p><div id="jpd.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>PRKN</i> (formerly <i>PARK2</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause parkin type of early-onset Parkinson disease.</p><p>Note: The detection frequency of all <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> types varies by population and depends mostly on the presence of a positive family history and the age at onset [<a class="bk_pop" href="#jpd.REF.abbas.1999.567">Abbas et al 1999</a>, <a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>, <a class="bk_pop" href="#jpd.REF.periquet.2001.617">Periquet et al 2001</a>, <a class="bk_pop" href="#jpd.REF.hedrich.2002.1239">Hedrich et al 2002</a>, <a class="bk_pop" href="#jpd.REF.west.2002.584">West et al 2002</a>, <a class="bk_pop" href="#jpd.REF.lohmann.2003.176">Lohmann et al 2003</a>, <a class="bk_pop" href="#jpd.REF.periquet.2003.1271">Periquet et al 2003</a>, <a class="bk_pop" href="#jpd.REF.poorkaj.2004.44">Poorkaj et al 2004</a>, <a class="bk_pop" href="#jpd.REF.wiley.2004.677">Wiley et al 2004</a>, <a class="bk_pop" href="#jpd.REF.wu.2005.82">Wu et al 2005</a>, <a class="bk_pop" href="#jpd.REF.marder.2010.731">Marder et al 2010</a>, <a class="bk_pop" href="#jpd.REF.kilarski.2012.1522">Kilarski et al 2012</a>]. The detection frequency of all types of pathogenic variants is as high as 80%-90% in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases with onset before age 20 years, and lower than 10% in individuals with no family history and onset around age 40 years. Otherwise, only 18%-26% of cases with a reported pathogenic variant had a juvenile onset, whereas 70% manifested the disease between the ages of 20 to 40 years, and 12% at 41 years or older (<a class="figpopup" href="/books/NBK1478/table/jpd.T.frequency_of_prkn_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figjpdTfrequencyofprknpathogenicvaria" rid-ob="figobjpdTfrequencyofprknpathogenicvaria">Table 2</a>) [<a class="bk_pop" href="#jpd.REF.periquet.2003.1271">Periquet et al 2003</a>, <a class="bk_pop" href="#jpd.REF.kasten.2010.670">Kasten et al 2010</a>]. A major caveat is that more than 50% of all published studies restricted their recruitment to those with young-onset disease [<a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>].</p><div id="jpd.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Parkin Type of Early-Onset Parkinson Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1478/table/jpd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jpd.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" scope="col" colspan="1" headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="3" scope="col" colspan="1" headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="3" scope="col" colspan="1" headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_3" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Family History</th></tr><tr><th headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_2_1" id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_3_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Positive</th><th headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_2_1" id="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_3_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Negative</th></tr></thead><tbody><tr><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKN</i></td><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup> / Scanning for pathogenic variants&#x000a0;<sup>5</sup></td><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_3_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">&#x02264;80%-90%&#x000a0;<sup>6</sup></td><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_3_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK1478/table/jpd.T.frequency_of_prkn_pathogenic_varia/?report=objectonly" target="object" rid-figpopup="figjpdTfrequencyofprknpathogenicvaria" rid-ob="figobjpdTfrequencyofprknpathogenicvaria">Table 2</a></td></tr><tr><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_jpd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Heterozygous deletions/<br />duplications/triplications&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="jpd.TF.1.1"><p class="no_margin">See <a href="/books/NBK1478/#jpd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="jpd.TF.1.2"><p class="no_margin">See <a href="#jpd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="jpd.TF.1.3"><p class="no_margin">The ability of the test method used to detect a variant that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="jpd.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="jpd.TF.1.5"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar variant detection frequencies; however, variant detection rates for scanning may vary considerably between laboratories depending on the specific protocol used.</p></div></dd><dt>6. </dt><dd><div id="jpd.TF.1.6"><p class="no_margin">Sequencing of the12 coding exons permits identification of the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants described so far, as well as small <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> rearrangements (1- or 2-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> deletions or insertions) [<a class="bk_pop" href="#jpd.REF.hattori.1998a.935">Hattori et al 1998a</a>, <a class="bk_pop" href="#jpd.REF.hattori.1998b.754">Hattori et al 1998b</a>, <a class="bk_pop" href="#jpd.REF.kitada.1998.605">Kitada et al 1998</a>, <a class="bk_pop" href="#jpd.REF.leroy.1998.424">Leroy et al 1998</a>, <a class="bk_pop" href="#jpd.REF.l_cking.1998.1355">L&#x000fc;cking et al 1998</a>, <a class="bk_pop" href="#jpd.REF.abbas.1999.567">Abbas et al 1999</a>, <a class="bk_pop" href="#jpd.REF.nisipeanu.1999.1602">Nisipeanu et al 1999</a>, <a class="bk_pop" href="#jpd.REF.maruyama.2000.245">Maruyama et al 2000</a>, <a class="bk_pop" href="#jpd.REF.mu_oz.2000.66">Mu&#x000f1;oz et al 2000</a>, <a class="bk_pop" href="#jpd.REF.hedrich.2004.1146">Hedrich et al 2004</a>].</p></div></dd><dt>7. </dt><dd><div id="jpd.TF.1.7"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="jpd.TF.1.8"><p class="no_margin">Exon rearrangements (i.e. deletions, duplications, and rarely, triplications of single or multiple exons) account for more than 50% of pathogenic variants [<a class="bk_pop" href="#jpd.REF.hedrich.2004.1146">Hedrich et al 2004</a>, <a class="bk_pop" href="#jpd.REF.marder.2010.731">Marder et al 2010</a>]. The frequency of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> rearrangements is likely even underestimated given that early variant screening studies did not include methods that aimed at identifying these types of variants. Deletions or duplications are frequently found in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state [<a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>].</p></div></dd></dl></div></div></div><div id="jpd.T.frequency_of_prkn_pathogenic_varia" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Frequency of <i>PRKN</i> Pathogenic Variants by Age at Onset in Individuals with Early-Onset Parkinson Disease and No Family History</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1478/table/jpd.T.frequency_of_prkn_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jpd.T.frequency_of_prkn_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age at Onset</th><th id="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Individuals w/<i>PRKN</i> Pathogenic Variants</th><th id="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total&#x000a0;<sup>1</sup></th><th id="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency</th><th id="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95% Confidence Interval</th></tr></thead><tbody><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;20 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">67%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38-88</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">20-24 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">27%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8-55</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25-29 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">24%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11-40</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30-34 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">53</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-18</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">35-39 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2-14</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">40-45 yrs</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">51</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-21</td></tr><tr><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Total</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">38&#x000a0;<sup>2</sup></td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">246&#x000a0;<sup>2</sup></td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15%</td><td headers="hd_h_jpd.T.frequency_of_prkn_pathogenic_varia_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11-20</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Adapted from <a class="bk_pop" href="#jpd.REF.periquet.2003.1271">Periquet et al [2003]</a> with permission</p></div></dd><dt>1. </dt><dd><div id="jpd.TF.2.1"><p class="no_margin">Including 100 cases from <a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al [2000]</a></p></div></dd><dt>2. </dt><dd><div id="jpd.TF.2.2"><p class="no_margin">Age at onset was not known for two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <i>PRKN</i> pathogenic variants and for one affected individual without a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; all three were younger than age 45 years when examined.</p></div></dd></dl></div></div></div><p><b>Interpretation of test results</b></p><ul><li class="half_rhythm"><div>The diagnosis of parkin type of early-onset Parkinson disease can only be confirmed when pathogenic variants are identified on both <i>PRKN</i> alleles (i.e., the individual is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the same pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> or a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for two different pathogenic alleles).</div></li><li class="half_rhythm"><div>The finding of a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is only suggestive (i.e., not diagnostic) of parkin type of early-onset Parkinson disease; the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may truly be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> and have parkinsonism from some other cause. In some series, even with individuals with early-onset Parkinson disease, the proportion of individuals with a single (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>) pathogenic variant is very high, up to 70% of parkin cases [<a class="bk_pop" href="#jpd.REF.poorkaj.2004.44">Poorkaj et al 2004</a>].</div><ul><li class="half_rhythm"><div>Those <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a single <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have on average about a nine-year later age at onset (39.9&#x000b1;13.3 years, n=232) than affected individuals with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants in <i>PRKN</i> (30.9&#x000b1;11.2 years, n=378) [<a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>].</div></li></ul></li><li class="half_rhythm"><div>A better understanding of the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, and <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency is needed to interpret the significance of single (<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>) pathogenic variants.</div></li><li class="half_rhythm"><div>The absence of a <i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on one or both alleles cannot completely exclude the diagnosis of parkin type of early-onset Parkinson disease.</div></li></ul></div></div><div id="jpd.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> identification of pathogenic variants on both <i>PRKN</i> alleles (i.e., the individual is <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the same pathogenic <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> or a compound <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> for two different pathogenic alleles) is required.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> One strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having parkin type of early-onset Parkinson disease is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>PRKN</i>.</p><p><b>Multigene panel.</b> Another strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having parkin type of early-onset Parkinson disease is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>.</p><p>Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. (5) Testing for pathogenic variants in <i>PRKN</i>, <i>PINK1</i>, and <i>DJ-1</i> is recommended in families with a recessive <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> or in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> cases in which an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has an early age at onset (&#x0003c;35 years [<a class="bk_pop" href="#jpd.REF.harbo.2009.777">Harbo et al 2009</a>] or &#x0003c;40 years [<a class="bk_pop" href="#jpd.REF.klein.2006.136">Klein &#x00026; Schlossmacher 2006</a>]).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div></div><div id="jpd.Clinical_Characteristics"><h2 id="_jpd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="jpd.Clinical_Description"><h3>Clinical Description</h3><p>Women and men are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with equal frequency. Age at onset is highly variable, even in individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#jpd.REF.chien.2006.13">Chien et al 2006</a>]; onset is usually before age 40 years, but some individuals may not develop disease until age 60 or 70 years [<a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.lohmann.2003.176">Lohmann et al 2003</a>].</p><p>Clinical signs vary; however, bradykinesia and tremor are the most common presenting signs. Dystonia is observed in 42% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Almost half of affected individuals present with hyperreflexia. A prolongation of the central motor conduction time points to involvement of the corticospinal tract [<a class="bk_pop" href="#jpd.REF.de_rosa.2006.275">De Rosa et al 2006</a>, <a class="bk_pop" href="#jpd.REF.schneider.2008.1812">Schneider et al 2008</a>, <a class="bk_pop" href="#jpd.REF.perretti.2011.546">Perretti et al 2011</a>] corresponding to the clinically observed hyperreflexia.</p><p>On average, the response to low doses of levodopa is excellent and sustained. The likelihood of developing levodopa-induced dyskinesias is higher than in individuals with parkinsonism resulting from other etiologies.</p><p>Parkin type of early-onset Parkinson disease is not associated with specific behavioral, neuropsychological, or psychiatric symptoms [<a class="bk_pop" href="#jpd.REF.caccappolo.2011.91">Caccappolo et al 2011</a>, <a class="bk_pop" href="#jpd.REF.srivastava.2011.740">Srivastava et al 2011</a>]. Cognitive impairment is uncommon, and dementia is observed very rarely [<a class="bk_pop" href="#jpd.REF.benbunan.2004.47">Benbunan et al 2004</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>].</p><p>In contrast to Parkinson disease of other etiologies, the sense of smell does not appear to be impaired in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants, whereas individuals with Parkinson disease and a heterozygous <i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> demonstrate typical hyposmia [<a class="bk_pop" href="#jpd.REF.alcalay.2011.319">Alcalay et al 2011</a>].</p><p>The disease is slowly progressive and disease duration of longer than 50 years has been reported.</p><p><b>Neuroimaging.</b> Routine cranial CT and MRI scans are usually normal.</p><p>PET/SPECT studies have revealed a reduced striatal <sup>18</sup>F-DOPA uptake and a reduced presynaptic dopamine transporter density in individuals with parkin type of early-onset Parkinson disease [<a class="bk_pop" href="#jpd.REF.van_der_vegt.2009.191">van der Vegt et al 2009</a>]. The putamen is predominantly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, consistent with the findings in Parkinson disease of other etiologies; in contrst, however, the loss of dopaminergic striatal innervation is rather symmetric and the progression rate is considerably slower. The postsynaptic D2 receptor density as assessed with <sup>11</sup>C-raclopride PET has been shown to be upregulated in untreated affected individuals and downregulated in affected individuals who receive dopaminergic medication.</p><p>Asymptomatic individuals who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> show a slight and subclinical impairment of dopaminergic neurotransmission. A longitudinal PET study demonstrated a very subtle progression rate, indicating that only a marginal number of asymptomatic individuals with a heterozygous pathogenic variant may develop clinically overt parkinsonism if no other risk factors are present [<a class="bk_pop" href="#jpd.REF.pavese.2009.2260">Pavese et al 2009</a>].</p><p>Voxel-based morphometry revealed a decrease of putaminal gray matter volume and a slight increase of gray matter in the right pallidum in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (those with two mutated alleles), whereas asymptomatic individuals with a single <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> demonstrated an increase of both putaminal and pallidal gray matter volume.</p><p>Using functional MRI, asymptomatic individuals with a single <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> showed an increased activation of motor-related brain regions when they performed repetitive finger movements [<a class="bk_pop" href="#jpd.REF.van_nuenen.2009.s703">van Nuenen et al 2009</a>]. The same mechanism of an increased neuronal recruitment has been illustrated for a facial emotion recognition task [<a class="bk_pop" href="#jpd.REF.anders.2012.1128">Anders et al 2012</a>].</p><p><b>Neuropathology.</b> To date, detailed post mortem studies of nine individuals with <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> and <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <i>PRKN</i> pathogenic variants have been published [<a class="bk_pop" href="#jpd.REF.poulopoulos.2012.831">Poulopoulos et al 2012</a>]. The most prominent and most common feature was the finding of neuronal loss in pigmented nuclei of the brain stem. Unlike Parkinson disease of other etiologies, the neuronal loss was stronger in the substantia nigra pars compacta than in the <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> coeruleus (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). Typical alpha-synuclein-containing Lewy bodies were identified in only two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, whereas one affected individual had basophilic Lewy body-like pathology of the pedunculopontine nucleus. Tau-containing neurofibrillary tangles were observed in two affected individuals. In conclusion, the spectrum of post mortem findings is broad and thus reminiscent of the situation in <i>LRRK2</i>-related Parkinson disease.</p></div><div id="jpd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Exon rearrangements of <i>PRKN</i> appear to have greater pathogenicity than single-nucleotide variants or small insertions/deletions, resulting in an association with an earlier age at onset [<a class="bk_pop" href="#jpd.REF.pankratz.2009.279">Pankratz et al 2009</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>]. No correlation between <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or truncating <i>PRKN</i> variants and age at onset, clinical presentation, or disease progression has been observed [<a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>]. Missense variants in known functional domains do not result in an earlier onset than missense variants in other regions of the protein [<a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>].</p></div><div id="jpd.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be nearly complete in individuals who have two <i>PRKN</i> pathogenic variants.</p></div><div id="jpd.Nomenclature"><h3>Nomenclature</h3><p>Families with parkin type of early-onset Parkinson disease were mostly described in Japan in the 1970s as having "<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> juvenile parkinsonism" (AR-JP).</p></div><div id="jpd.Prevalence"><h3>Prevalence</h3><p>The population-based prevalence is largely unknown. However, in Europe, parkin type of early-onset Parkinson disease accounts for approximately 50% of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> parkinsonism and 18% of parkinsonism in individuals without a family history and an onset before age 45 years [<a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>]. The percentage of parkin type of early-onset Parkinson disease cases rapidly decreases with increasing age at onset. After age 30 years, only a few percent of individuals representing <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (parkinsonism in a single individual in a family) are found to have <i>PRKN</i> pathogenic variants. However, in families with a clear-cut autosomal recessive <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>, the age-related decrease is less pronounced [<a class="bk_pop" href="#jpd.REF.periquet.2003.1271">Periquet et al 2003</a>].</p><p>Prevalence of parkin type of early-onset Parkinson disease appears to be similar in all populations. Individuals with parkin type of early-onset Parkinson disease from many different regions have been reported [<a class="bk_pop" href="#jpd.REF.hattori.1998a.935">Hattori et al 1998a</a>, <a class="bk_pop" href="#jpd.REF.hattori.1998b.754">Hattori et al 1998b</a>, <a class="bk_pop" href="#jpd.REF.leroy.1998.424">Leroy et al 1998</a>, <a class="bk_pop" href="#jpd.REF.l_cking.1998.1355">L&#x000fc;cking et al 1998</a>, <a class="bk_pop" href="#jpd.REF.abbas.1999.567">Abbas et al 1999</a>, <a class="bk_pop" href="#jpd.REF.nisipeanu.1999.1602">Nisipeanu et al 1999</a>, <a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.maruyama.2000.245">Maruyama et al 2000</a>, <a class="bk_pop" href="#jpd.REF.mu_oz.2000.66">Mu&#x000f1;oz et al 2000</a>, <a class="bk_pop" href="#jpd.REF.biswas.2006.420">Biswas et al 2006</a>, <a class="bk_pop" href="#jpd.REF.vinish.2010.166">Vinish et al 2010</a>, <a class="bk_pop" href="#jpd.REF.guerrero_camacho.2012.1047">Guerrero Camacho et al 2012</a>, <a class="bk_pop" href="#jpd.REF.semenova.2012.139">Semenova et al 2012</a>].</p></div></div><div id="jpd.Genetically_Related_Allelic_Disorder"><h2 id="_jpd_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Heterozygous <i>PRKN</i> pathogenic variants have been detected in a large number of individuals with Parkinson disease, raising the question of whether <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants may contribute to the development of parkinsonism [<a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.west.2002.584">West et al 2002</a>, <a class="bk_pop" href="#jpd.REF.oliveira.2003.624">Oliveira et al 2003</a>, <a class="bk_pop" href="#jpd.REF.klein.2007.652">Klein et al 2007</a>]. Case-control studies revealed a frequency of 0 to 7.9% in people with Parkinson disease and 0 to 3.7% of neurologically healthy control subjects [<a class="bk_pop" href="#jpd.REF.gr_newald.2012">Gr&#x000fc;newald &#x00026; Klein 2012</a>]. The frequency of heterozygous <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> rearrangements was the same among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> persons and control subjects in a comprehensive case-control study [<a class="bk_pop" href="#jpd.REF.kay.2010.1189">Kay et al 2010</a>]. Notably, however, the frequency of <i>PRKN</i> pathogenic variants in public <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> databases is only 0.17% in presumably healthy individuals.</p><p>Multimodal neuroimaging and electrophysiologic studies disclosed latent nigrostriatal impairment in asymptomatic individuals with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>PRKN</i> pathogenic variants, supporting the assumption that heterozygous pathogenic variants are a genetic susceptibility factor for Parkinson disease [<a class="bk_pop" href="#jpd.REF.van_der_vegt.2009.191">van der Vegt et al 2009</a>]. In addition, pseudo-dominant inheritance (i.e., one of the parents is also <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>) has been reported in some families with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <i>PRKN</i> pathogenic variants [<a class="bk_pop" href="#jpd.REF.maruyama.2000.245">Maruyama et al 2000</a>, <a class="bk_pop" href="#jpd.REF.bonifati.2001.531">Bonifati et al 2001</a>, <a class="bk_pop" href="#jpd.REF.l_cking.2001.924">L&#x000fc;cking et al 2001</a>, <a class="bk_pop" href="#jpd.REF.kobayashi.2003.11">Kobayashi et al 2003</a>]. However, based on the currently available data (and lack of prospective evaluations), the role of heterozygous <i>PRKN</i> pathogenic variants cannot be determined conclusively.</p><p>Pathogenic variants in <i>PRKN</i> have also been associated with cancer [<a class="bk_pop" href="#jpd.REF.veeriah.2010.77">Veeriah et al 2010</a>], leprosy [<a class="bk_pop" href="#jpd.REF.mira.2004.636">Mira et al 2004</a>], and autism [<a class="bk_pop" href="#jpd.REF.glessner.2009.569">Glessner et al 2009</a>]. The involvement of <i>PRKN</i> pathogenic variants in oncogenesis is, however, ambiguous, as the association with cancer could not be replicated in a population-based study [<a class="bk_pop" href="#jpd.REF.alcalay.2012.1109">Alcalay et al 2012</a>].</p></div><div id="jpd.Differential_Diagnosis"><h2 id="_jpd_Differential_Diagnosis_">Differential Diagnosis</h2><p>Parkinson disease multigene panels may include testing for a number of the genes associated with disorders discussed in this section.</p><p>Parkin type of early-onset Parkinson disease and Parkinson disease of other etiologies are difficult to distinguish by clinical examination (see <a href="/books/n/gene/parkinson-overview/">Parkinson Disease Overview</a>). More than 80% of individuals with Parkinson disease have no family history of the disorder. Several monogenic forms account for a number of cases with a positive family history.</p><p>Pathogenic variants in <i>PINK1</i> are the second most common cause of early-onset Parkinson disease, after <i>PRKN</i>. Cases associated with pathogenic variants in <i>PRKN</i> and <i>PINK1</i> are clinically indistinguishable on an individual basis [<a class="bk_pop" href="#jpd.REF.ib__ez.2006.686">Ib&#x000e1;&#x000f1;ez et al 2006</a>] (see <a href="/books/n/gene/pink1-pd/"><i>PINK1</i> Type of Young-Onset Parkinson Disease</a>).</p><p>Another disorder in the differential diagnosis is the <i>DJ1</i>- type of early-onset Parkinson disease, which also presents as an early-onset disorder with an overall similar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> to that of the parkin type of early-onset Parkinson disease [<a class="bk_pop" href="#jpd.REF.bonifati.2003.256">Bonifati et al 2003</a>].</p><p>For individuals with juvenile-onset Parkinson disease, especially those with prominent dystonia, dopa-responsive dystonia should be considered; for example, <a href="/books/n/gene/drd/">GTP cyclohydrolase 1-deficient dopa-responsive dystonia</a>, caused by pathogenic variants in <i>GCH1</i>.</p></div><div id="jpd.Management"><h2 id="_jpd_Management_">Management</h2><div id="jpd.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with parkin type of early-onset Parkinson disease, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Assess the presence and the severity of parkinsonian signs, non-motor features and treatment-related complications using the Unified Parkinson's disease rating scale (UPDRS) [<a class="bk_pop" href="#jpd.REF.fahn.1987">Fahn &#x00026; Elton 1987</a>] or the Movement Disorder Society (MDS) UPDRS [<a class="bk_pop" href="#jpd.REF.goetz.2008.2129">Goetz et al 2008</a>].</div></li><li class="half_rhythm"><div>Assess the presence of atypical signs, such as hyperreflexia and dystonia.</div></li><li class="half_rhythm"><div>Evaluate the degree of response to treatment.</div></li><li class="half_rhythm"><div>Assess for cognitive or behavioral problems.</div></li><li class="half_rhythm"><div>Consider consultation with a clinical geneticist and/or genetic counselor.</div></li></ul></div><div id="jpd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>To date, the treatment of parkin type of early-onset Parkinson disease is not different from that of Parkinson disease of other etiologies. No specific guidelines are currently available.</p><ul><li class="half_rhythm"><div>The motor impairment usually responds very well to low doses of dopaminergic medication and is typically sustained even after long disease duration.</div></li><li class="half_rhythm"><div>The most relevant treatment-related problem is the early occurrence of levodopa-induced dyskinesias (abnormal involuntary movements) and motor fluctuations. The management of treatment-related complications is not different from the strategies applied in Parkinson disease of other etiologies, and includes deep brain stimulation in selected cases [<a class="bk_pop" href="#jpd.REF.moro.2008.1186">Moro et al 2008</a>].</div></li></ul></div><div id="jpd.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>To reduce or delay side effects, levodopa doses should not exceed the levels required for satisfactory clinical response.</p></div><div id="jpd.Surveillance"><h3>Surveillance</h3><p>Neurologic follow-up every six to 12 months to modify treatment as needed is appropriate.</p></div><div id="jpd.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Neuroleptic treatment may exacerbate parkinsonism.</p></div><div id="jpd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#jpd.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="jpd.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy in women with Parkinson disease is a rare event. Only one case of a successful pregnancy in a woman with parkin type of early-onset Parkinson disease has been reported [<a class="bk_pop" href="#jpd.REF.serikawa.2011.72">Serikawa et al 2011</a>]. The 27-year old woman successfully gave birth to spontaneously conceived dichorionic/diamnionic male twins. Exacerbation of her motor disabilities was noted during late pregnancy. She was treated with levodopa/carbidopa only during the period of organogenesis. Both babies were born healthy, without any evidence of psychomotor impairment two years after birth.</p><p>Worsening of parkinsonian symptoms could in part be explained by the reduction of dopaminergic replacement therapy. If possible, dopaminergic medication should be limited to levodopa/decarboxylase inhibitor to minimize the potential risk for teratogenicity at least over the course of the embryonic phase.</p></div><div id="jpd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="jpd.Genetic_Counseling"><h2 id="_jpd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="jpd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Parkin type of early-onset Parkinson disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="jpd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (except in the as-yet unreported event of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>[s] occurring <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>).</div></li><li class="half_rhythm"><div>The risk to heterozygotes of developing symptoms is not yet conclusively determined; however, several individuals with parkinsonism who carry a single <i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported [<a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.west.2002.584">West et al 2002</a>, <a class="bk_pop" href="#jpd.REF.lohmann.2003.176">Lohmann et al 2003</a>, <a class="bk_pop" href="#jpd.REF.oliveira.2003.624">Oliveira et al 2003</a>, <a class="bk_pop" href="#jpd.REF.klein.2007.652">Klein et al 2007</a>].</div></li><li class="half_rhythm"><div>In rare instances, a parent may also be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> based on the presence of two pathogenic alleles [<a class="bk_pop" href="#jpd.REF.maruyama.2000.245">Maruyama et al 2000</a>, <a class="bk_pop" href="#jpd.REF.bonifati.2001.531">Bonifati et al 2001</a>, <a class="bk_pop" href="#jpd.REF.l_cking.2001.924">L&#x000fc;cking et al 2001</a>, <a class="bk_pop" href="#jpd.REF.kobayashi.2003.11">Kobayashi et al 2003</a>, <a class="bk_pop" href="#jpd.REF.pellecchia.2007.559">Pellecchia et al 2007</a>]. This occurrence in any <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorder is termed pseudo-dominant inheritance.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the chance of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li><li class="half_rhythm"><div>The risk to heterozygotes of developing symptoms is not yet conclusively determined, although several individuals with parkinsonism who carry a single <i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been reported [<a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.west.2002.584">West et al 2002</a>, <a class="bk_pop" href="#jpd.REF.lohmann.2003.176">Lohmann et al 2003</a>, <a class="bk_pop" href="#jpd.REF.oliveira.2003.624">Oliveira et al 2003</a>, <a class="bk_pop" href="#jpd.REF.klein.2007.652">Klein et al 2007</a>, <a class="bk_pop" href="#jpd.REF.brooks.2009.375">Brooks et al 2009</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with parkin type of early-onset Parkinson disease are obligate heterozygotes.</div></li><li class="half_rhythm"><div>The risk to offspring of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> depends on the frequency of heterozygotes, which is 0%-3.7% in the general population [<a class="bk_pop" href="#jpd.REF.gr_newald.2012">Gr&#x000fc;newald &#x00026; Klein 2012</a>], thus generating a risk of 0%-1% to offspring of being affected. As for other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders, the risk is higher when the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and his/her reproductive partner are related.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each sib of the proband's parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</p></div><div id="jpd.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing using molecular genetic techniques is possible if the pathogenic variants have been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div><div id="jpd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="jpd.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>PRKN</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="jpd.Resources"><h2 id="_jpd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Parkinson Disease Association (APDA)</b></div><div>135 Parkinson Avenue</div><div>Staten Island NY 10305</div><div><b>Phone:</b> 800-223-2732 (toll-free); 718-981-8001</div><div><b>Fax:</b> 718-981-4399</div><div><b>Email:</b> apda@apdaparkinson.org</div><div><a href="http://www.apdaparkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.apdaparkinson.org</a></div></li><li class="half_rhythm"><div><b>Fox Trial Finder</b></div><div><a href="https://foxtrialfinder.michaeljfox.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">foxtrialfinder.michaeljfox.org/</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="https://medlineplus.gov/parkinsonsdisease.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson's Disease</a></div></li><li class="half_rhythm"><div><b>Michael J. Fox Foundation for Parkinson's Research</b></div><div>Church Street Station</div><div>PO Box 780</div><div>New York NY 10008-0780</div><div><b>Phone:</b> 800-708-7644 (toll-free)</div><div><b>Email:</b> info@michaeljfox.org</div><div><a href="http://www.michaeljfox.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.michaeljfox.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Parkinson%27s%20disease&#x00026;parent=Disease%20Risk&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson Disease</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-Disease-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson's Disease Information Page</a></div></li><li class="half_rhythm"><div><b>Parkinson&#x02019;s Disease Society (UK)</b></div><div>United Kingdom</div><div><b>Phone:</b> 0808 800 0303</div><div><b>Email:</b> hello@parkinsons.org.uk</div><div><a href="https://www.parkinsons.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinsons.org.uk</a></div></li><li class="half_rhythm"><div><b>Parkinson's Foundation</b></div><div>200 SE 1st Street</div><div>Suite 800</div><div>Miami FL 33131</div><div><b>Phone:</b> 800-4PD-INFO (473-4636)</div><div><b>Email:</b> contact@parkinson.org</div><div><a href="http://www.parkinson.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.parkinson.org</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=parkinsondisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson disease</a></div></li></ul></div><div id="jpd.Molecular_Genetics"><h2 id="_jpd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="jpd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Parkin Type of Early-Onset Parkinson Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1478/table/jpd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jpd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_jpd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_jpd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_jpd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_jpd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_jpd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_jpd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_jpd.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_jpd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">PARK2</td><td headers="hd_b_jpd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5071" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PRKN</i></a></td><td headers="hd_b_jpd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5071" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">6q26</a></td><td headers="hd_b_jpd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O60260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">E3 ubiquitin-protein ligase parkin</a></td><td headers="hd_b_jpd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://reseq.biosciencedbc.jp/resequence/GeneDetail.do?targetId=2&#x00026;geneId=EG5071" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PD mutation database (PARK2)</a><br /><a href="http://www.LOVD.nl/PARK2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Parkinson's disease Mutation Database (PARK2)</a></td><td headers="hd_b_jpd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRKN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKN</a></td><td headers="hd_b_jpd.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PRKN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="jpd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="jpd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Parkin Type of Early-Onset Parkinson Disease (<a href="/omim/600116,602544" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1478/table/jpd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jpd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600116" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600116</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602544" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602544</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PARKIN; PARK2</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PRKN</i> (formerly <i>PARK2</i>) is the second largest human <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> spanning approximately 1.35 Mb. It consists of 12 coding exons separated by large <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions. See <a href="/books/NBK1478/#jpd.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of gene and protein information.</p><p><b>Benign variants.</b> Many <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> variants have been detected; four of them cause amino acid changes (<a class="figpopup" href="/books/NBK1478/table/jpd.T.prkn_selected_benign_variants/?report=objectonly" target="object" rid-figpopup="figjpdTprknselectedbenignvariants" rid-ob="figobjpdTprknselectedbenignvariants">Table 3</a>). The frequency of the particular benign variants varies by geographic location [<a class="bk_pop" href="#jpd.REF.abbas.1999.567">Abbas et al 1999</a>, <a class="bk_pop" href="#jpd.REF.wang.1999.655">Wang et al 1999</a>, <a class="bk_pop" href="#jpd.REF.lincoln.2003.1306">Lincoln et al 2003</a>, <a class="bk_pop" href="#jpd.REF.l_cking.2003.1253">L&#x000fc;cking et al 2003</a>].</p><div id="jpd.T.prkn_selected_benign_variants" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p><i>PRKN</i> Selected Benign Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1478/table/jpd.T.prkn_selected_benign_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__jpd.T.prkn_selected_benign_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.500G&#x0003e;A</td><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser167Asn</td><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/4758883" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004562<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/4758884" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004553<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1096C&#x0003e;T</td><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg366Trp</td></tr><tr><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1138G&#x0003e;C</td><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val380Leu</td></tr><tr><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1182G&#x0003e;A</td><td headers="hd_h_jpd.T.prkn_selected_benign_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp394Asn</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Pathogenic variants.</b> More than 180 pathogenic variants of <i>PRKN</i> have been described; half are situated in the region spanning exons 2 to 4 [<a class="bk_pop" href="#jpd.REF.corti.2011.1161">Corti et al 2011</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>]. Several of the pathogenic variants are recurrent [<a class="bk_pop" href="#jpd.REF.hattori.1998a.935">Hattori et al 1998a</a>, <a class="bk_pop" href="#jpd.REF.hattori.1998b.754">Hattori et al 1998b</a>, <a class="bk_pop" href="#jpd.REF.leroy.1998.424">Leroy et al 1998</a>, <a class="bk_pop" href="#jpd.REF.l_cking.1998.1355">L&#x000fc;cking et al 1998</a>, <a class="bk_pop" href="#jpd.REF.abbas.1999.567">Abbas et al 1999</a>, <a class="bk_pop" href="#jpd.REF.nisipeanu.1999.1602">Nisipeanu et al 1999</a>, <a class="bk_pop" href="#jpd.REF.klein.2000.65">Klein et al 2000</a>, <a class="bk_pop" href="#jpd.REF.maruyama.2000.245">Maruyama et al 2000</a>, <a class="bk_pop" href="#jpd.REF.mu_oz.2000.66">Mu&#x000f1;oz et al 2000</a>, <a class="bk_pop" href="#jpd.REF.hedrich.2002.1239">Hedrich et al 2002</a>, <a class="bk_pop" href="#jpd.REF.periquet.2003.1271">Periquet et al 2003</a>, <a class="bk_pop" href="#jpd.REF.rawal.2003.1378">Rawal et al 2003</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2012">Gr&#x000fc;newald &#x00026; Klein 2012</a>]. Different types of <i>PRKN</i> variants are found at variable frequencies. Changes have been identified in the <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a>, <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>, and heterozygous state.</p><ul><li class="half_rhythm"><div><i>PRKN</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> rearrangements (deletions or duplications; rarely triplications) of single or multiple exons account for more than 50% of all <i>PRKN</i> pathogenic variants [<a class="bk_pop" href="#jpd.REF.hedrich.2004.1146">Hedrich et al 2004</a>, <a class="bk_pop" href="#jpd.REF.marder.2010.731">Marder et al 2010</a>, <a class="bk_pop" href="#jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald et al 2013</a>]. The frequency of exon rearrangements is likely even underestimated given that early variant screening studies did not include methods that aimed at identifying these types of variants. Gene dosage alterations lead to internal deletions or premature protein truncation [<a class="bk_pop" href="#jpd.REF.l_cking.2000.1560">L&#x000fc;cking et al 2000</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of exon 3 is the most frequent <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKN</i>. Importantly, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> exon rearrangements cannot be detected by conventional sequencing.</div></li><li class="half_rhythm"><div>Most of the <i>PRKN</i> single-nucleotide variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. The most common <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> is the c.924C&#x0003e;T, in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 7. Nonsense variants, one- or two-<a class="def" href="/books/n/gene/glossary/def-item/base-pair/">base pair</a> deletions, or small insertions result in a frameshift that either predicts or is known to cause truncated parkin.</div></li></ul><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The normal gene product, parkin, is a 465-amino acid protein, which contains a ubiquitin-like <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the N terminus and a RING (Really Interesting New Gene) domain composed of three RING finger motifs (RING0, 1, and 2). RING1 and 2 are separated by a sequence without any recognizable domain structure (in between-RING (IBR). Parkin is mainly localized in the cytoplasm under basal conditions. Like other RING finger proteins, parkin exhibits E3 ubiquitin ligase activity [<a class="bk_pop" href="#jpd.REF.imai.2000.35661">Imai et al 2000</a>, <a class="bk_pop" href="#jpd.REF.shimura.2000.302">Shimura et al 2000</a>, <a class="bk_pop" href="#jpd.REF.zhang.2000.13354">Zhang et al 2000</a>] and mediates the ubiquitination of a number of proteins, thus targeting them for proteasomal degradation. Parkin can additionally mediate non-degradative modes of ubiquitination, which appear to be required for the survival of nigrostriatal dopaminergic neurons [<a class="bk_pop" href="#jpd.REF.moore.2006.749">Moore 2006</a>]. More than twenty of its substrates have yet been identified. In addition to its role as E3 ligase, parkin is also involved in the maintenance of mitochondrial function and integrity, and protection from multiple stressors, hence acting as neuroprotectant. In the context of its role in mitochondrial metabolism, parkin interacts with PINK1, another protein linked to <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, early-onset parkinsonism [<a class="bk_pop" href="#jpd.REF.valente.2004.1158">Valente et al 2004</a>]. PINK1 promotes the mitochondrial <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of parkin, thus enabling parkin to ubiquinate mitochondrial proteins, to selectively identify impaired mitochondria, and to trigger their degradation by mitophagy [<a class="bk_pop" href="#jpd.REF.narendra.2012">Narendra et al 2012</a>, <a class="bk_pop" href="#jpd.REF.rakovic.2013.2223">Rakovic et al 2013</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> It is postulated that the vast majority of <i>PRKN</i> pathogenic variants produce a loss of function of normal E3 ubiquitin ligase activity by the absence of the protein (truncating variants) or its inactivation (<a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants). <i>PRKN</i> pathogenic variants impair the ubiquitination of mitofusins, which are highly relevant mitochondrial fusion and fission factors [<a class="bk_pop" href="#jpd.REF.rakovic.2011.e16746">Rakovic et al 2011</a>]. The pathogenic variants could also result in the accumulation of its substrates because they are no longer appropriately targeted to the proteasome system for their degradation. However, this hypothesis has not been confirmed in appropriate experimental models. As an example, degeneration does not occur in the substantia nigra of different lines of mice with inactivation of <i>PRKN</i>. In addition, in vitro studies have shown that the consequences of pathogenic variants may vary according to their nature and their location (e.g., decreased expression, abnormal aggregation, decreased interaction with substrates and/or E2 ubiquitin transferases). According to their involvement in mitochondrial integrity, <i>PRKN</i> pathogenic variants were demonstrated to result in reduction of mitochondrial complex I activity, disruption of the mitochondrial morphology, and impairment of protection of mitochondrial <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> integrity from oxidative stress.</p></div><div id="jpd.References"><h2 id="_jpd_References_">References</h2><div id="jpd.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="jpd.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 7-2-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 7-2-19.</div></li></ul></div><div id="jpd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.abbas.1999.567">Abbas N, L&#x000fc;cking CB, Ricard S, Durr A, Bonifati V, De Michele G, Bouley S, Vaughan JR, Gasser T, Marconi R, Broussolle E, Brefel-Courbon C, Harhangi BS, Oostra BA, Fabrizio E, Bohme GA, Pradier L, Wood NW, Filla A, Meco G, Denefle P, Agid Y, Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:567–74.</span> [<a href="/pubmed/10072423" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10072423</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.alcalay.2012.1109">Alcalay RN, Clark LN, Marder KS, Bradley WE. Lack of association between cancer history and PARKIN genotype: a family based study in PARKIN/Parkinson's families. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2012;<span class="ref-vol">51</span>:1109–13.</span> [<a href="/pmc/articles/PMC3465486/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3465486</span></a>] [<a href="/pubmed/22927236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22927236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.alcalay.2011.319">Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Comella C, Colcher A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Rezak M, Novak KE, Friedman JH, Pfeiffer R, Marsh L, Hiner B, Clark LN, Marder K. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:319–26.</span> [<a href="/pmc/articles/PMC3034420/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3034420</span></a>] [<a href="/pubmed/21205674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21205674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.anders.2012.1128">Anders S, Sack B, Pohl A, M&#x000fc;nte T, Pramstaller P, Klein C, Binkofski F. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele. <span><span class="ref-journal">Brain. </span>2012;<span class="ref-vol">135</span>:1128–40.</span> [<a href="/pmc/articles/PMC3326258/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3326258</span></a>] [<a href="/pubmed/22434215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22434215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.benbunan.2004.47">Benbunan BR, Korczyn AD, Giladi N. Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's disease. <span><span class="ref-journal">J Neural Transm. </span>2004;<span class="ref-vol">111</span>:47–57.</span> [<a href="/pubmed/14714215" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14714215</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.biswas.2006.420">Biswas A, Gupta A, Naiya T, Das G, Neogi R, Datta S, Mukherjee S, Das SK, Ray K, Ray J. Molecular pathogenesis of Parkinson's disease: identification of mutations in the Parkin gene in Indian patients. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2006;<span class="ref-vol">12</span>:420–6.</span> [<a href="/pubmed/16793319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16793319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.bonifati.2001.531">Bonifati V, L&#x000fc;cking CB, Fabrizio E, Periquet M, Meco G, Brice A. Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2001;<span class="ref-vol">71</span>:531–4.</span> [<a href="/pmc/articles/PMC1763498/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1763498</span></a>] [<a href="/pubmed/11561042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11561042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.bonifati.2003.256">Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">299</span>:256–9.</span> [<a href="/pubmed/12446870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12446870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.brooks.2009.375">Brooks J, Ding J, Simon-Sanchez J, Paisan-Ruiz C, Singleton AB, Scholz SW. Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. <span><span class="ref-journal">J Med Genet. </span>2009;<span class="ref-vol">46</span>:375–81.</span> [<a href="/pmc/articles/PMC4767009/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4767009</span></a>] [<a href="/pubmed/19351622" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19351622</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.caccappolo.2011.91">Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Cote LJ, Frucht S, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Siderowf AD, Ross BM, Verbitsky M, Kisselev S, Ottman R, Clark LN, Marder KS. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. <span><span class="ref-journal">J Int Neuropsychol Soc. </span>2011;<span class="ref-vol">17</span>:91–100.</span> [<a href="/pmc/articles/PMC3366462/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366462</span></a>] [<a href="/pubmed/21092386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21092386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.chien.2006.13">Chien HF, Rohe CF, Costa MD, Breedveld GJ, Oostra BA, Barbosa ER, Bonifati V. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from northeastern Brazil. <span><span class="ref-journal">Neurogenetics. </span>2006;<span class="ref-vol">7</span>:13–9.</span> [<a href="/pubmed/16328510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16328510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.corti.2011.1161">Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson's disease. <span><span class="ref-journal">Physiol Rev. </span>2011;<span class="ref-vol">91</span>:1161–218.</span> [<a href="/pubmed/22013209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22013209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.de_rosa.2006.275">De Rosa A, Volpe G, Marcantonio L, Santoro L, Brice A, Filla A, Perretti A, De Michele G. Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations. <span><span class="ref-journal">J Neurol. </span>2006;<span class="ref-vol">253</span>:275–9.</span> [<a href="/pubmed/16502212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16502212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.fahn.1987">Fahn S, Elton RL. UPDRS program members: Unified Parkinsons Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. <em>Recent Developments in Parkinson&#x02019;s Disease</em>. Vol 2. Florham Park, NJ: Macmillan Healthcare Information; 1987:153-63.</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.glessner.2009.569">Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">459</span>:569–73.</span> [<a href="/pmc/articles/PMC2925224/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2925224</span></a>] [<a href="/pubmed/19404257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19404257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.goetz.2008.2129">Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N., Movement Disorder Society UPDRS Revision Task Force.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:2129–70.</span> [<a href="/pubmed/19025984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19025984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.gr_newald.2013.1186">Gr&#x000fc;newald A, Kasten M, Ziegler A, Klein C. Next generation phenotyping using the Parkin example: Time to catch up with genetics. <span><span class="ref-journal">JAMA Neurol. </span>2013;<span class="ref-vol">70</span>:1186–91.</span> [<a href="/pubmed/23835509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23835509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.gr_newald.2012">Gr&#x000fc;newald A, Klein C. Parkin-associated Parkinson&#x02019;s disease. In: Pfeiffer RF, Wszolek ZK, Ebadi M, eds: <em>Parkinson&#x02019;s Disease</em>. 2 ed. Chap 14. Boca Raton, FL: CRC Press; 2012.</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.guerrero_camacho.2012.1047">Guerrero Camacho JL, Monroy Jaramillo N, Yescas G&#x000f3;mez P, Rodr&#x000ed;guez Violante M, Boll Woehrlen C, Alonso Vilatela ME, L&#x000f3;pez L&#x000f3;pez M. High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1047–51.</span> [<a href="/pubmed/22777964" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22777964</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.harbo.2009.777">Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Sch&#x000f6;ls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T. EFNS. EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias. <span><span class="ref-journal">Eur J Neurol. </span>2009;<span class="ref-vol">16</span>:777–85.</span> [<a href="/pubmed/19469830" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19469830</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.hattori.1998a.935">Hattori N, Kitada T, Matsumine H, Asakawa S, Yamamura Y, Yoshino H, Kobayashi T, Yokochi M, Wang M, Yoritaka A, Kondo T, Kuzuhara S, Nakamura S, Shimizu N, Mizuno Y. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. <span><span class="ref-journal">Ann Neurol. </span>1998a;<span class="ref-vol">44</span>:935–41.</span> [<a href="/pubmed/9851438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9851438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.hattori.1998b.754">Hattori N, Matsumine H, Asakawa S, Kitada T, Yoshino H, Elibol B, Brookes AJ, Yamamura Y, Kobayashi T, Wang M, Yoritaka A, Minoshima S, Shimizu N, Mizuno Y. Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1998b;<span class="ref-vol">249</span>:754–8.</span> [<a href="/pubmed/9731209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9731209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.hedrich.2004.1146">Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-Santana H, Vieregge P, Jacobs H, Bressman SB, Lang AE, Kann M, Abbruzzese G, Martinelli P, Schwinger E, Ozelius LJ, Pramstaller PP, Klein C, Kramer P. Distribution, type, and origin of Parkin mutations: review and case studies. <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:1146–57.</span> [<a href="/pubmed/15390068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.hedrich.2002.1239">Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:1239–46.</span> [<a href="/pubmed/11971093" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11971093</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.ib__ez.2006.686">Ib&#x000e1;&#x000f1;ez P, Lesage S, Lohmann E, Thobois S, De Michele G, Borg M, Agid Y, Durr A, Brice A. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:686–94.</span> [<a href="/pubmed/16401616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16401616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.imai.2000.35661">Imai Y, Soda M, Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:35661–4.</span> [<a href="/pubmed/10973942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.kasten.2010.670">Kasten M, Kertelge L, Bruggemann N, van der Vegt J, Schmidt A, Tadic V, Buhmann C, Steinlechner S, Behrens MI, Ramirez A, Binkofski F, Siebner H, Raspe H, Hagenah J, Lencer R, Klein C. Nonmotor symptoms in genetic Parkinson disease. <span><span class="ref-journal">Arch Neurol. </span>2010;<span class="ref-vol">67</span>:670–676.</span> [<a href="/pubmed/20558386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20558386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.kay.2010.1189">Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, Bird T, Nutt J, Schellenberg GD, Payami H. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:1189–94.</span> [<a href="/pmc/articles/PMC3013490/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3013490</span></a>] [<a href="/pubmed/20876472" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20876472</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.kilarski.2012.1522">Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1522–9.</span> [<a href="/pubmed/22956510" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22956510</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.kitada.1998.605">Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">392</span>:605–8.</span> [<a href="/pubmed/9560156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9560156</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.klein.2007.652">Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE. Deciphering the role of heterozygous mutations in genes associated with parkinsonism. <span><span class="ref-journal">Lancet Neurol. </span>2007;<span class="ref-vol">6</span>:652–62.</span> [<a href="/pubmed/17582365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17582365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.klein.2000.65">Klein C, Pramstaller PP, Kis B, Page CC, Kann M, Leung J, Woodward H, Castellan CC, Scherer M, Vieregge P, Breakefield XO, Kramer PL, Ozelius LJ. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:65–71.</span> [<a href="/pubmed/10894217" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10894217</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.klein.2006.136">Klein C, Schlossmacher MG. The genetics of Parkinson disease: Implications for neurological care. <span><span class="ref-journal">Nat Clin Pract Neurol. </span>2006;<span class="ref-vol">2</span>:136–46.</span> [<a href="/pubmed/16932540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16932540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.kobayashi.2003.11">Kobayashi T, Matsumine H, Zhang J, Imamichi Y, Mizuno Y, Hattori N. Pseudo-autosomal dominant inheritance of PARK2: two families with parkin gene mutations. <span><span class="ref-journal">J Neurol Sci. </span>2003;<span class="ref-vol">207</span>:11–7.</span> [<a href="/pubmed/12614925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12614925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.leroy.1998.424">Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH. Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. <span><span class="ref-journal">Hum Genet. </span>1998;<span class="ref-vol">103</span>:424–7.</span> [<a href="/pubmed/9856485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9856485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.lincoln.2003.1306">Lincoln SJ, Maraganore DM, Lesnick TG, Bounds R, de Andrade M, Bower JH, Hardy JA, Farrer MJ. Parkin variants in North American Parkinson's disease: cases and controls. <span><span class="ref-journal">Mov Disord. </span>2003;<span class="ref-vol">18</span>:1306–11.</span> [<a href="/pubmed/14639672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14639672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.lohmann.2003.176">Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM, Fraix V, Broussolle E, Horstink MW, Vidailhet M, Verpillat P, Gasser T, Nicholl D, Teive H, Raskin S, Rascol O, Destee A, Ruberg M, Gasparini F, Meco G, Agid Y, Durr A, Brice A. How much phenotypic variation can be attributed to parkin genotype? <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:176–85.</span> [<a href="/pubmed/12891670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12891670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.l_cking.1998.1355">L&#x000fc;cking CB, Abbas N, Durr A, Bonifati V, Bonnet AM, de Broucker T, De Michele G, Wood NW, Agid Y, Brice A. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. <span><span class="ref-journal">Lancet. </span>1998;<span class="ref-vol">352</span>:1355–6.</span> [letter] [<a href="/pubmed/9802278" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9802278</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.l_cking.2001.924">L&#x000fc;cking CB, Bonifati V, Periquet M, Vanacore N, Brice A, Meco G. Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">57</span>:924–7.</span> [<a href="/pubmed/11552035" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11552035</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.l_cking.2003.1253">L&#x000fc;cking CB, Chesneau V, Lohmann E, Verpillat P, Dulac C, Bonnet AM, Gasparini F, Agid Y, Durr A, Brice A. Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease. <span><span class="ref-journal">Arch Neurol. </span>2003;<span class="ref-vol">60</span>:1253–6.</span> [<a href="/pubmed/12975291" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12975291</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.l_cking.2000.1560">L&#x000fc;cking CB, Durr A, Bonifati V, Vaughan J, De Michele G, Gasser T, Harhangi BS, Meco G, Denefle P, Wood NW, Agid Y, Brice A. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. <span><span class="ref-journal">N Engl J Med. </span>2000;<span class="ref-vol">342</span>:1560–7.</span> [<a href="/pubmed/10824074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10824074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.marder.2010.731">Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, Waters C, Fahn S, Ross BM, Cote LJ, Frucht S, Ford B, Alcalay RN, Rezak M, Novak K, Friedman JH, Pfeiffer RF, Marsh L, Hiner B, Neils GD, Verbitsky M, Kisselev S, Caccappolo E, Ottman R, Clark LN. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. <span><span class="ref-journal">Arch Neurol. </span>2010;<span class="ref-vol">67</span>:731–8.</span> [<a href="/pmc/articles/PMC3329757/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3329757</span></a>] [<a href="/pubmed/20558392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20558392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.maruyama.2000.245">Maruyama M, Ikeuchi T, Saito M, Ishikawa A, Yuasa T, Tanaka H, Hayashi S, Wakabayashi K, Takahashi H, Tsuji S. Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:245–50.</span> [<a href="/pubmed/10939576" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939576</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.mira.2004.636">Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Dore C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E. Susceptibility to leprosy is associated with PARK2 and PACRG. <span><span class="ref-journal">Nature. </span>2004;<span class="ref-vol">427</span>:636–40.</span> [<a href="/pubmed/14737177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14737177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.moore.2006.749">Moore DJ. Parkin: a multifaceted ubiquitin ligase. <span><span class="ref-journal">Biochem Soc Trans. </span>2006;<span class="ref-vol">34</span>:749–753.</span> [<a href="/pubmed/17052189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17052189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.moro.2008.1186">Moro E, Volkmann J, Konig IR, Winkler S, Hiller A, Hassin-Baer S, Herzog J, Schnitzler A, Lohmann K, Pinsker MO, Voges J, Djarmatic A, Seibler P, Lozano AM, Rogaeva E, Lang AE, Deuschl G, Klein C. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:1186–91.</span> [<a href="/pubmed/18378882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18378882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.mu_oz.2000.66">Mu&#x000f1;oz E, Pastor P, Marti MJ, Oliva R, Tolosa E. A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism. <span><span class="ref-journal">Neurosci Lett. </span>2000;<span class="ref-vol">289</span>:66–8.</span> [<a href="/pubmed/10899410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10899410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.narendra.2012">Narendra D, Walker JE, Youle R. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. <span><span class="ref-journal">Cold Spring Harb Perspect Biol. </span>2012;<span class="ref-vol">4</span>(11)</span> [<a href="/pmc/articles/PMC3536340/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3536340</span></a>] [<a href="/pubmed/23125018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23125018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.nisipeanu.1999.1602">Nisipeanu P, Inzelberg R, Blumen SC, Carasso RL, Hattori N, Matsumine H, Mizuno Y. Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of Parkin gene. <span><span class="ref-journal">Neurology. </span>1999;<span class="ref-vol">53</span>:1602–4.</span> [<a href="/pubmed/10534280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10534280</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.oliveira.2003.624">Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH Jr, Scott BL, Goetz CG, Small GW, Mastaglia F, Stajich JM, Zhang F, Booze MW, Winn MP, Middleton LT, Haines JL, Pericak-Vance MA, Vance JM. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">53</span>:624–9.</span> [<a href="/pubmed/12730996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12730996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.pankratz.2009.279">Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">73</span>:279–86.</span> [<a href="/pmc/articles/PMC2715211/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2715211</span></a>] [<a href="/pubmed/19636047" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19636047</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.pavese.2009.2260">Pavese N, Khan NL, Scherfler C, Cohen L, Brooks DJ, Wood NW, Bhatia KP, Quinn NP, Lees AJ, Piccini P. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span>:2260–6.</span> [<a href="/pubmed/19845000" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19845000</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.pellecchia.2007.559">Pellecchia MT, Varrone A, Annesi G, Amboni M, Cicarelli G, Sansone V, Annesi F, Rocca FE, Vitale C, Pappat&#x000e0; S, Quattrone A, Barone P. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. <span><span class="ref-journal">Mov Disord. </span>2007;<span class="ref-vol">22</span>:559–63.</span> [<a href="/pubmed/17149727" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17149727</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.periquet.2003.1271">Periquet M, Latouche M, Lohmann E, Rawal N, De Michele G, Ricard S, Teive H, Fraix V, Vidailhet M, Nicholl D, Barone P, Wood NW, Raskin S, Deleuze JF, Agid Y, Durr A, Brice A. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. <span><span class="ref-journal">Brain. </span>2003;<span class="ref-vol">126</span>:1271–8.</span> [<a href="/pubmed/12764050" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12764050</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.periquet.2001.617">Periquet M, L&#x000fc;cking C, Vaughan J, Bonifati V, D&#x000fc;rr A, De Michele G, Horstink M, Farrer M, Illarioshkin SN, Pollak P, Borg M, Brefel-Courbon C, Denefle P, Meco G, Gasser T, Breteler MM, Wood N, Agid Y, Brice A, et al.  The European Consortium on Genetic Susceptibility in Parkinson's Disease. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:617–26.</span> [<a href="/pmc/articles/PMC1274475/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274475</span></a>] [<a href="/pubmed/11179010" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11179010</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.perretti.2011.546">Perretti A, De Rosa A, Marcantonio L, Iodice V, Estraneo A, Manganelli F, Garavaglia B, Filla A, Santoro L, De Michele G. Neurophysiological evaluation of motor corticospinal pathways by TMS in idiopathic early-onset Parkinson's disease. <span><span class="ref-journal">Clin Neurophysiol. </span>2011;<span class="ref-vol">122</span>:546–9.</span> [<a href="/pubmed/20797900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20797900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.poorkaj.2004.44">Poorkaj P, Nutt JG, James D, Gancher S, Bird TD, Steinbart E, Schellenberg GD, Payami H. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">129A</span>:44–50.</span> [<a href="/pubmed/15266615" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15266615</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.poulopoulos.2012.831">Poulopoulos M, Levy OA, Alcalay RN. The neuropathology of genetic Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:831–42.</span> [<a href="/pmc/articles/PMC3383342/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3383342</span></a>] [<a href="/pubmed/22451330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22451330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.rakovic.2011.e16746">Rakovic A, Grunewald A, Kottwitz J, Bruggemann N, Pramstaller PP, Lohmann K, Klein C. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts. <span><span class="ref-journal">PLoS One. </span>2011;<span class="ref-vol">6</span>:e16746.</span> [<a href="/pmc/articles/PMC3050809/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3050809</span></a>] [<a href="/pubmed/21408142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21408142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.rakovic.2013.2223">Rakovic A, Shurkewitsch K, Seibler P, Gr&#x000fc;newald A, Zanon A, Hagenah J, Krainc D, Klein C. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. <span><span class="ref-journal">J Biol Chem. </span>2013;<span class="ref-vol">288</span>:2223–37.</span> [<a href="/pmc/articles/PMC3554895/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3554895</span></a>] [<a href="/pubmed/23212910" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23212910</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.rawal.2003.1378">Rawal N, Periquet M, Lohmann E, L&#x000fc;cking CB, Teive HA, Ambrosio G, Raskin S, Lincoln S, Hattori N, Guimaraes J, Horstink MW, Dos Santos Bele W, Brousolle E, Destee A, Mizuno Y, Farrer M, Deleuze JF, De Michele G, Agid Y, Durr A, Brice A. New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:1378–81.</span> [<a href="/pubmed/12707451" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12707451</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.schneider.2008.1812">Schneider SA, Talelli P, Cheeran BJ, Khan NL, Wood NW, Rothwell JC, Bhatia KP. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations. <span><span class="ref-journal">Mov Disord. </span>2008;<span class="ref-vol">23</span>:1812–9.</span> [<a href="/pubmed/18759365" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18759365</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.semenova.2012.139">Semenova EV, Shadrina MI, Slominsky PA, Ivanova-Smolenskaya IA, Bagyeva G, Illarioshkin SN, Limborska SA. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:139–42.</span> [<a href="/pubmed/21915905" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21915905</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.serikawa.2011.72">Serikawa T, Shimohata T, Akashi M, Yokoseki A, Tsuchiya M, Hasegawa A, Haino K, Koike R, Takakuwa K, Tanaka K, Nishizawa M. Successful twin pregnancy in a patient with parkin-associated autosomal recessive juvenile parkinsonism. <span><span class="ref-journal">BMC neurology. </span>2011;<span class="ref-vol">11</span>:72.</span> [<a href="/pmc/articles/PMC3135525/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135525</span></a>] [<a href="/pubmed/21682904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21682904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.shimura.2000.302">Shimura H, Hattori N, Kubo S, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">25</span>:302–5.</span> [<a href="/pubmed/10888878" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10888878</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.srivastava.2011.740">Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, Andrews H, Waters C, Fahn S, Cote L, Frucht S, Ford B, Alcalay RN, Ross B, Orbe Reilly M, Rezak M, Novak K, Friedman JH, Pfeiffer RD, Marsh L, Hiner B, Merle D, Ottman R, Clark LN, Marder K. The relation between depression and parkin genotype: the CORE-PD study. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2011;<span class="ref-vol">17</span>:740–4.</span> [<a href="/pmc/articles/PMC3221786/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3221786</span></a>] [<a href="/pubmed/21856206" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21856206</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.valente.2004.1158">Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">304</span>:1158–60.</span> [<a href="/pubmed/15087508" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15087508</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.van_der_vegt.2009.191">van der Vegt JP, van Nuenen BF, Bloem BR, Klein C, Siebner HR. Imaging the impact of genes on Parkinson's disease. <span><span class="ref-journal">Neuroscience. </span>2009;<span class="ref-vol">164</span>:191–204.</span> [<a href="/pubmed/19409223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19409223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.van_nuenen.2009.s703">van Nuenen BF, van Eimeren T, van der Vegt JP, Buhmann C, Klein C, Bloem BR, Siebner HR. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. <span><span class="ref-journal">Mov Disord. </span>2009;<span class="ref-vol">24</span> Suppl 2:S703–10.</span> [<a href="/pubmed/19877238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19877238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.veeriah.2010.77">Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. <span><span class="ref-journal">Nature genetics. </span>2010;<span class="ref-vol">42</span>:77–82.</span> [<a href="/pmc/articles/PMC4002225/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4002225</span></a>] [<a href="/pubmed/19946270" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19946270</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.vinish.2010.166">Vinish M, Prabhakar S, Khullar M, Verma I, Anand A. Genetic screening reveals high frequency of PARK2 mutations and reduced Parkin expression conferring risk for Parkinsonism in North West India. <span><span class="ref-journal">Journal of neurology, neurosurgery, and psychiatry. </span>2010;<span class="ref-vol">81</span>:166–70.</span> [<a href="/pubmed/19734163" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19734163</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.wang.1999.655">Wang M, Hattori N, Matsumine H, Kobayashi T, Yoshino H, Morioka A, Kitada T, Asakawa S, Minoshima S, Shimizu N, Mizuno Y. Polymorphism in the parkin gene in sporadic Parkinson's disease. <span><span class="ref-journal">Ann Neurol. </span>1999;<span class="ref-vol">45</span>:655–8.</span> [see comments] [<a href="/pubmed/10319889" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10319889</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.west.2002.584">West A, Periquet M, Lincoln S, L&#x000fc;cking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF, Maraganore D, Levey A, Wood N, Durr A, Hardy J, Brice A, Farrer M. Complex relationship between Parkin mutations and Parkinson disease. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">114</span>:584–91.</span> [<a href="/pubmed/12116199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12116199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.wiley.2004.677">Wiley J, Lynch T, Lincoln S, Skipper L, Hulihan M, Gosal D, Bisceglio G, Kachergus J, Hardy J, Farrer MJ. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations. <span><span class="ref-journal">Mov Disord. </span>2004;<span class="ref-vol">19</span>:677–81.</span> [<a href="/pubmed/15197707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15197707</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.wu.2005.82">Wu RM, Bounds R, Lincoln S, Hulihan M, Lin CH, Hwu WL, Chen J, Gwinn-Hardy K, Farrer M. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. <span><span class="ref-journal">Arch Neurol. </span>2005;<span class="ref-vol">62</span>:82–7.</span> [<a href="/pubmed/15642853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15642853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="jpd.REF.zhang.2000.13354">Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2000;<span class="ref-vol">97</span>:13354–9.</span> [<a href="/pmc/articles/PMC27228/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC27228</span></a>] [<a href="/pubmed/11078524" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11078524</span></a>]</div></li></ul></div></div><div id="jpd.Chapter_Notes"><h2 id="_jpd_Chapter_Notes_">Chapter Notes</h2><div id="jpd.Author_History"><h3>Author History</h3><p>Alexis Brice, MD; H&#x000f4;pital de la Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re (2001-2013)<br />Norbert Br&#x000fc;ggemann, MD (2013-present)<br />Alexandra D&#x000fc;rr, MD, PhD; H&#x000f4;pital de la Piti&#x000e9;-Salp&#x000ea;tri&#x000e8;re (2001-2013)<br />Christine Klein, MD (2013-present) <br />Christoph L&#x000fc;cking, MD; Ludwig-Maximilians University (2001-2013)</p></div><div id="jpd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>4 April 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 November 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</div></li><li class="half_rhythm"><div>8 July 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 November 2003 (ab) Revisions</div></li><li class="half_rhythm"><div>3 October 2003 (cd) Revision: change in test availability</div></li><li class="half_rhythm"><div>6 June 2003 (ca) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 April 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>November 2000 (ab) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1478</span><span class="label">PMID: <a href="/pubmed/20301651" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301651</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/pkan/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/parkinson-overview/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1478&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1478/?report=reader">PubReader</a></li><li><a href="/books/NBK1478/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1478" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1478" style="display:none" title="Cite this Page"><div class="bk_tt">Brüggemann N, Klein C. Parkin Type of Early-Onset Parkinson Disease. 2001 Apr 17 [Updated 2013 Apr 4]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1478/pdf/Bookshelf_NBK1478.pdf">PDF version of this page</a> (468K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#jpd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#jpd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#jpd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#jpd.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#jpd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#jpd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#jpd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#jpd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#jpd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#jpd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#jpd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5071[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRKN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1478+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1479338" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1479338" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1479338" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1479338" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301792" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PINK1</i> Type of Young-Onset Parkinson Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PINK1</i> Type of Young-Onset Parkinson Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Schneider SA, Klein C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301610" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Tyrosine Hydroxylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Furukawa Y, Kish S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28796472" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">VPS35</i>-Related Parkinson Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">VPS35</i>-Related Parkinson Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Deutschländer A, Ross OA, Wszolek ZK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28749637" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301294" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">ATP1A3-</i>Related Neurologic Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Brashear A, Sweadner KJ, Cook JF, Swoboda KJ, Ozelius L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301651" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301651" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc9473dde0891169d6ec17">Parkin Type of Early-Onset Parkinson Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Parkin Type of Early-Onset Parkinson Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:29:23-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8ADAA1DFC87C5100000000063F0339&amp;ncbi_session=CE8ADAA1DFC94721_1599SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1478%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1478&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1478/&amp;ncbi_pagename=Parkin Type of Early-Onset Parkinson Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8ADAA1DFC94721_1599SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>